Investigation Projects

"Innovation is an attitude"

Diego Arroyo PhD. Molecular biologist. General Manager

Development of products for pathogens detection and identification
(RealCycler products)

This investigation line focuses on the acquisition of new products that allow the detection of virus, bacteria, fungi and parasites in a sensible and efficent way. We are currently putting in great effort to develop detection systems for the bacteria resistances, as the appearance of organisms resistant to antibiotics is a first-rate healthy problem.

Development of products for the study of genetic diseases

This line of research has made the development of products possible that enable the detection of polymorphism related to genetic diseases, such as the thrombophilia, hemochromatosis and Alzheimers

This line of investigation has been carried out in two product lines. On the one hand the RealType line includes exclusive products of our company, and on the other hand the Thrombo inCode y Cardio inCode products jointly developed with Gendiag and Ferrer inCode.

Development of new genetic diagnostic tests

This line allows the incorporation of new genetic diseases in our catalogue. Thanks to the incorporation of the new generation sequencing (NGS) we are able to conduct de diagnostic of one hundred multigenic diseases through the study of selected genes panels.  

Software development

Progenie molecular develops software called BioVisor©.

BioVisor© NGS allows the study of mutations obtained through exome sequencing. BioVisor RealCycler and BioVisor RealType facilitate the interpretation of results obtained with the RealCycler products (pathogens detection and quantification) and the RealType products (genotyping through Real-Time PCR), respectively.

We have also developed the Progestor software, that allows the management of clinical samples and their results.

Description of new genetic mutations

In our laboratory we frequently discover changes in DNA that have not been previously described. This leads to the opportunity of developing a basic research activity that materializes in scientific publications and communications in congresses.

We cooperate with the international scientific community in the registration of these mutations in genetic databases to help the diagnosis of patients throughout the world.

PYME innovadora seal

Progenie molecular has been recognized with the PYME innovadora seal. In this way, our intense research activity in the molecular diagnostic field is certified.